argenx SE (ARGNF)
PNK: ARGNF
· Real-Time Price · USD
697.42
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 604.7 |
| Market Cap | 42.58B |
| Revenue (ttm) | 2.15B |
| Net Income (ttm) | 805.17M |
| EPS (ttm) | 12.76 |
| PE Ratio (ttm) | 54.66 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 697.42 |
| Volume | 5 |
| Avg. Volume (20D) | 17.577 |
| Open | 695.15 |
| Previous Close | 697.42 |
| Day's Range | 695.15 - 697.42 |
| 52-Week Range | 373.50 - 697.42 |
| Beta | 0.20 |
About ARGNF
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid ...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 30, 2015
Employees 1,599
Stock Exchange PNK
Ticker Symbol ARGNF
Website https://www.argenx.com